AVVie is a visionary and EU-funded startup in the thriving field of structural heart medical devices, headquartered in Vienna.

 

More than 13 million people in Europe and the US suffer from mitral valve regurgitation (blood leaking back into the heart´s left atrium) but only less then 5% of moderate to severely ill patients get treated. Our mission is to enhance the quality of life for millions of individuals suffering from mitral valve regurgitation, a pressing global health concern.

​

AVVie has developed the Mitral Butterfly system, a novel innovative solution for patients suffering from mitral regurgitation and subsequent heart failure. Mitral Butterfly is a hemi valve replacing the function of the native, dysfunctioning posterior leaflet.